Evidence map›Paper›PMID 33115835›Full record

ArticlemSphere2020

Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret.

Dominique J Barbeau, Joseph R Albe, Sham Nambulli, Natasha L Tilston-Lunel, Amy L Hartman, Seema S Lakdawala, Ed Klein, W Paul Duprex, Anita K McElroy

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.3field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Laboratory Animal Models for Rift Valley Fever Virus Disease.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Dominique J BarbeauUniversity of Pittsburgh, School of Medicine, Department of Pediatrics, Division of Pediatric infectious Disease, Pittsburgh, Pennsylvania, USA.
Joseph R AlbeUniversity of Pittsburgh, School of Public Health, Department of Infectious Disease and Microbiology, Pittsburgh, Pennsylvania, USA.
Sham NambulliUniversity of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, USA.
Natasha L Tilston-LunelUniversity of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, USA.
Amy L HartmanUniversity of Pittsburgh, School of Public Health, Department of Infectious Disease and Microbiology, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-0857-2973
Seema S LakdawalaUniversity of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, USA.
Ed KleinUniversity of Pittsburgh, School of Medicine, Division of Laboratory Animal Research, Pittsburgh, Pennsylvania, USA.
W Paul DuprexUniversity of Pittsburgh, Center for Vaccine Research, Pittsburgh, Pennsylvania, USA.
Anita K McElroyUniversity of Pittsburgh, School of Medicine, Department of Pediatrics, Division of Pediatric infectious Disease, Pittsburgh, Pennsylvania, USA mcelroya@pitt.edu.ORCID 0000-0001-6764-7536
University of Pittsburgh · US

Funding

Live-attenuated Rift Valley fever vaccines: comparative mechanisms of trans-placental transmission and vaccine efficacy for developing fetusesR01AI150792 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARTMAN, AMY L · 2020 to 2025
$3.7M
Neuroprotective anti-inflammatory drugs as a novel combination therapy for neurological Rift Valley FeverR01NS101100 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARTMAN, AMY L · 2017 to 2021
$1.7M
Immune correlates of protection from Rift Valley fever virusK08AI119448 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCELROY, ANITA K · 2016 to 2019
$713k
NIAID NIH HHS K08 AI119448NIAID NIH HHS R01 AI150792NINDS NIH HHS R01 NS101100
6 · The paper itself

Abstract

Rift Valley fever virus (RVFV) is a pathogen of both humans and livestock in Africa and the Middle East. Severe human disease is associated with hepatitis and/or encephalitis. Current pathogenesis studies rely on rodents and nonhuman primates, which have advantages and disadvantages. We evaluated disease progression in

Indexed as

Acute DiseaseAnimalsBrainDisease Models, AnimalEncephalitis, ViralFerretsMaleRift Valley FeverRift Valley fever virusanimal modelencephalitisferretpathogenesisRift Valley fever virus

Identifiers

PMID33115835
PMCPMC7593599
OpenAlexW3096143071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.